Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Sarepta Therapeutics (SRPT)

Sarepta Therapeutics (SRPT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,992,943
  • Shares Outstanding, K 87,501
  • Annual Sales, $ 701,890 K
  • Annual Income, $ -418,780 K
  • 60-Month Beta 1.29
  • Price/Sales 8.58
  • Price/Cash Flow N/A
  • Price/Book 7.03
Trade SRPT with:

Options Overview Details

View History
  • Implied Volatility 57.24% ( -2.45%)
  • Historical Volatility 46.26%
  • IV Percentile 42%
  • IV Rank 16.77%
  • IV High 114.76% on 01/06/22
  • IV Low 45.65% on 10/20/21
  • Put/Call Vol Ratio 0.89
  • Today's Volume 1,685
  • Volume Avg (30-Day) 493
  • Put/Call OI Ratio 0.54
  • Today's Open Interest 38,462
  • Open Int (30-Day) 44,668

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate -1.12
  • Number of Estimates 6
  • High Estimate -0.97
  • Low Estimate -1.28
  • Prior Year -1.02
  • Growth Rate Est. (year over year) -9.80%

Price Performance

See More
Period Period Low Period High Performance
1-Month
61.28 +15.80%
on 05/12/22
77.26 -8.15%
on 05/05/22
-1.85 (-2.54%)
since 04/26/22
3-Month
61.28 +15.80%
on 05/12/22
89.55 -20.76%
on 04/08/22
-5.07 (-6.67%)
since 02/25/22
52-Week
61.28 +15.80%
on 05/12/22
101.24 -29.91%
on 10/08/21
-3.99 (-5.32%)
since 05/26/21

Most Recent Stories

More News
Bausch (BHC) Q1 Earnings and Revenues Miss, Stock Down

Bausch (BHC) misses on earnings and sales in the first quarter due to incremental macro pressures and a challenging supply chain environment.

ALKS : 29.36 (+1.77%)
SRPT : 70.90 (+3.52%)
ABEO : 0.1541 (+0.52%)
BHC : 9.86 (+2.92%)
Bayer (BAYRY) Earnings & Revenues Surpass Estimates in Q1

Bayer (BAYRY) beats estimates for both earnings and revenues in the first quarter of 2022.

REGN : 683.44 (-1.08%)
JNJ : 179.46 (-0.09%)
BAYRY : 17.6400 (+3.34%)
SRPT : 70.90 (+3.52%)
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?

Sector ETF report for FBT

FBT : 133.78 (+1.13%)
EXEL : 18.19 (+2.13%)
IBB : 115.80 (+0.90%)
NBIX : 89.84 (+1.65%)
SRPT : 70.90 (+3.52%)
XBI : 68.47 (+1.09%)
Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?

Smart Beta ETF report for FBT

FBT : 133.78 (+1.13%)
EXEL : 18.19 (+2.13%)
IBB : 115.80 (+0.90%)
NBIX : 89.84 (+1.65%)
SRPT : 70.90 (+3.52%)
XBI : 68.47 (+1.09%)
Sarepta (SRPT) Q1 Earnings Beat, DMD Drugs' Sales Robust

Strong demand for Sarepta's (SRPT) DMD drugs boosts its top line in the first quarter. Stock up in after-market trading.

RHHBY : 43.3200 (+0.77%)
SRPT : 70.90 (+3.52%)
XNCR : 22.36 (+0.58%)
LYEL : 4.09 (-0.49%)
Sarepta Therapeutics (SRPT) Q1 2022 Earnings Call Transcript

SRPT earnings call for the period ending March 31, 2022.

SRPT : 70.90 (+3.52%)
Sarepta Therapeutics (SRPT) Reports Q1 Loss, Tops Revenue Estimates

Sarepta Therapeutics (SRPT) delivered earnings and revenue surprises of 11.11% and 3.59%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

SRPT : 70.90 (+3.52%)
TWST : 34.72 (-1.28%)
Sarepta Therapeutics to Present at the BofA Securities 2022 Healthcare Conference

CAMBRIDGE, Mass., May 04, 2022 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases,...

SRPT : 70.90 (+3.52%)
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CAMBRIDGE, Mass., April 29, 2022 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare...

SRPT : 70.90 (+3.52%)
Sarepta Therapeutics to Announce First Quarter 2022 Financial Results and Recent Corporate Developments on May 4, 2022

CAMBRIDGE, Mass., April 27, 2022 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare...

SRPT : 70.90 (+3.52%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company that focuses on the discovery and development of RNA-based therapeutics targeting rare and infectious diseases. It concentrates on the development of exon-skipping drug candidates targeting Duchenne muscular dystrophy (DMD), a...

See More

Key Turning Points

3rd Resistance Point 72.76
2nd Resistance Point 71.63
1st Resistance Point 70.06
Last Price 70.90
1st Support Level 67.36
2nd Support Level 66.23
3rd Support Level 64.66

See More

52-Week High 101.24
Fibonacci 61.8% 85.98
Fibonacci 50% 81.26
Fibonacci 38.2% 76.54
Last Price 70.90
52-Week Low 61.28

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar